Becoming Bio develops novel biologics targeting autoimmune diseases through innovative protein engineering.
This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.
Becoming Bio provides foundational biology infrastructure complementary to Substrate's technology substrate; one of three most exciting investments currently inflecting.